Letter to the FDA Calling for Full Transparency Regarding Coronavirus-Related Drug Shortages
On February 27, 2020, the Food and Drug Administration (FDA) announced the first known medication shortage linked to the COVID-19 outbreak that originated in China. The agency, however, has refused to disclose the name of the medication. Public Citizen urged the FDA to publicly identify the drugs that are involved in any shortage resulting from the COVID-19 epidemic.
March 30, 2020, FDA response letter.
See Public Citizen’s other work on FDA transparency.
See Public Citizen’s other work on drug shortages.
See Public Citizen’s other work on the coronavirus pandemic.